title: [Upper urinary tract tumors: results of treatment and follow-up].
abstract: OBJECTIVE
  To present the results of treatment and follow-up of 105 patients with tumor of the upper urinary tract.
  
  
  METHODS
  A retrospective study was conducted on 105 patients (88 male and 17 female; mean age 68.3 years) with tumor of the upper urinary tract that had been treated from 1975 to 1997. In total 114 functional units were treated, including recurrences and bilateral tumors. The sites of involvement were: ureter (49.9%), pelvis (41.2%) and the entire upper urinary tract (8.7%). Ninety-six percent were transitional cell carcinomas: 4.8% were well differentiated (GI), 68% moderately differentiated (G2) and 26.8% poorly differentiated (G3); 58.6% were superficial, while 41.3% showed tumor invasion into or beyond the muscle layer. Ninety-two of the 105 patients were followed. The SPSS program was employed for the statistical analysis. The survival was calculated by the Kaplan-Meier method and the differences by the log rank test. Multivariance analysis was performed using the Cox regression method.
  
  
  RESULTS
  
  
  
  METHODS
  58% underwent radical nephroureterectomy, 30% were treated conservatively and 11.6% underwent partial resection of the upper urinary tract. Recurrence: 8.7% of the patients showed tumor recurrence. The recurrence rate after conservative surgery was 13.6% and was as high as 80% in the remaining ureter. Metastasis: 22.8% of the patients presented metastasis to the retroperitoneal lymph nodes, bone, liver and lungs. Survival: In the univariate analysis tumor stage, age, radical and conservative surgery were found to influence survival, while stage and surgery (radical or conservative) were found to be statistically important by multivariate analysis.
  
  
  CONCLUSIONS
  The treatment of choice for high grade and stage transitional cell carcinoma is by radical surgery, whereas for the superficial and well differentiated tumors, conservative management can achieve similar survival rates while preserving the renal unit and upper urinary tract.
authors.affiliation: Servicio de Urología, Hospital Son Dureta, Palma de Mallorca, España.
authors.forename: D
authors.initials: D
authors.lastname: Muñoz Vélez
authors.forename: M
authors.initials: M
authors.lastname: Rebassa Llull
authors.forename: F
authors.initials: F
authors.lastname: Hidalgo Pardo
authors.forename: V
authors.initials: V
authors.lastname: Riera Marí
authors.forename: A
authors.initials: A
authors.lastname: Mus Malleu
authors.forename: C
authors.initials: C
authors.lastname: Gutiérrez Sanz-Gadea
authors.forename: M
authors.initials: M
authors.lastname: Ozonas Moragues
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D012189:Retrospective Studies; D014571:Urologic Neoplasms / Q000628:therapy*
vernacular_title: Tumores del tracto urinario superior: resultados del tratamiento y seguimiento.